期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

新活素治疗老年患者心肌梗死后难治性心力衰竭疗效观察 被引量：6

下载PDF
导出
摘要 目的观察新活素对心肌梗死后难治性心力衰竭老年患者的治疗效果。方法 62例心肌梗死后心力衰竭患者经常规抗心衰药物治疗无效后加用新活素,观察治疗前后各临床指标,进行临床疗效的评价。结果应用新活素治疗后,左室射血分数、小轴缩短率、每搏输出量、每分输出量较治疗前升高,心率较治疗前降低,总有效率为88.7%。结论新活素能改善心肌梗死后难治性心力衰竭患者的心功能,提高治疗有效率。
作者 李旭红 李洁茹
机构地区 山西省太原市第二人民医院
出处 《中西医结合心脑血管病杂志》 2013年第9期1064-1065,共2页 Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease
关键词 心肌梗死 难治性心力衰竭 新活素 心功能
分类号 R541.6 [医药卫生—心血管疾病]
  • 相关文献

参考文献10

  • 1孙树印,张瑞华,李慧.新活素治疗急性心力衰竭临床观察[J].临床合理用药杂志,2010,3(6):1-2. 被引量：34
  • 2Burger AJ. A review of the renal and neurohormonal effects of B - type natriuretie peptide[J]. Congest Heart Fail, 2005,11 (1) : 30 - 38.
  • 3陈玉累.新活素治疗难治性心力衰竭的疗效观察与护理[J].中国校医,2011,25(10):754-755. 被引量：4
  • 4Balion CM, Santaguida P, Mckelvie R, et al. Physiological, patho logical, pharmacological, biochemical and hematological factors af- fecting BNP and NT - pro BNP[J]. Clin Biochem, 2008,41 (4 - 5) : 231 -239.
  • 5Tanner H, Mohacsi P, Fuller - Bicer GA, et al. Cytokine activationand disease progression in patients with stable moderate chronic heart failure[J]. J Heart Lung Transplant, 2007,26 (6) : 622 - 629.
  • 6Kawakami R, Saito Y, Kishimoto I, et al. Overexpression of brain natriuretic peptide facilitates neutrophil infiltration and cardiac ma- trix metalloproteinase - 9 expression after acute myocardial infarc- tion[J]. Circulation, 2004,110(21) : 3306 - 3312.
  • 7Krum H, Liew D. New and emerging drug therapies for the man- agement of acute heart failure[J]. Intern Med J, 2003,33 (11) : 515 - 520.
  • 8Kapoun AM, Liang F, OYoung G, et al. B- type natriuretic peptide exerts broad functional opposition to transforming growth factor- beta in primary human cardiac fibroblastsFibrosis, myofibroblast, conversion,proliferation,and inflammation[J]. Circ Res, 2004, 94 (4) :453 -461.
  • 9Porcu M, Cacciatore G. Intervention strategies in refractory heart failure[J]. Ital Heart J Suppl,2002,3(8) :791 - 792.
  • 10李敏,刘佳,于萍.新活素治疗难治性心力衰竭21例的观察与护理[J].吉林医学,2009,30(20):2440-2441. 被引量：7

二级参考文献15

  • 1方圻,王士雯,宁田海,朱文玲,张运,邵耕,林传骧,浦寿月,顾复生,徐成斌,戚文航,程显声,戴闺柱.充血性心力衰竭诊断和治疗对策[J].中华心血管病杂志,1995,23(2):83-94. 被引量：361
  • 2陈华,王晓惠,金伟华.新活素[J].中国新药杂志,2006,15(5):393-394. 被引量：39
  • 3付尧,杨光,白小涓,贾大林,马玉龙,齐国先.重组人脑利钠肽治疗充血性心力衰竭的疗效评价[J].中国医科大学学报,2006,35(2):191-192. 被引量：35
  • 4Andrew J. A review of the renal and neurohormonal effects of B - type natriuretic peptide [ J ]. Congest Heart Fail (CHF) , 2005,11(1) :30.
  • 5Kawakami R,Saito Y,Kishimoto I,et al.Over expression of brain natriuretic peptide facilitates neutrophil infiltration and cardiac matrix metalloproteinase 29 expression after acute myocardial infarction[J].Circulation,2004,110(21):3306-3312.
  • 6Elkayam U,Akhter MW,Singh H,et al.Comparison of effects on left ventricular filling pressure of intravenous nesiritide and high-dose nitroglycerin in patients with decompensated heart failure[J].Am J Cardiol,2004,93(2):237-240.
  • 7Yancy CW,Saltzberg MT,Berkowitz RL,et al.Safety and feasibility of using serial infusions of nesiritide for heart failure in an out patientsetting(from the FUSION I trial)[J].Am J Cardiol,2004,94(5):595-601.
  • 8Witteles RM,Kao D,Christopherson D,et al.Impact of nesiritide on renal function in patients with acute decompensated heart failure and pre-existing renal dysfunction a randomized,double-blind,placebo-controlled clinical trial[J].J Am Coll Cardiol,2007,50(19):1835-1840.
  • 9Arora S,Clarke K,Srinivasan V,et al.Effect of nesiritide on renal function in patients admitted for decompensated heart failure[J].QJM,2007,100(11):699-706.
  • 10Cynthuia MB,Pasqualina S,Robert M,et al.Physiological,pathological,phar-macological,biochemical and hematologica factors affecting BNP and NT-pro BNP[J].Clinical Biochemistry,2008,41(4-5):231-239.

共引文献39

同被引文献70

  • 1皇甫卫忠.新活素对慢性心力衰竭的心功能、高敏c反应蛋白及血浆脑利钠肽的影响.中国循环杂志,2013,(z1):88-88.
  • 2陆再英,钟南山.西医内科学[M].北京:人民卫生出版社,2011.
  • 3Fenario CM, Schiffrin EL,Role of mineralocorticoid receptor antagonists in cardiovascular disease[J].circ Res,2015, 116(1):206-213.
  • 4Pilt B,Zannad F, Remme WJ,et al.The effect of spironolactone on morbidity and mortality in patients wiMh severe heart failure Randomized Aldactone Evaluation Study Investigators[J].N Engl J Med, 1999,341 (10):709-717.
  • 5Bisping E,Wakula P, Poteser M,et al.Targeting cardiac hypertrophy:toward a causal heart failure therapy[J].J Cardiovasc Pharrnacol,2014,64(4):293-305.
  • 6Lehtonen L,Poder EThe utility of levosimendan in the treatment of heart failure[J].Ann Med,2007,39(1):2.
  • 7Rouleau JL,Pfeffer MA, Stewart DJ, et al. Comparison of vasopeptidase inhibitor, omapatrilat,and lisinopril on exercise tolerance and morbidity in patients with heart failure:IMPRESS randomized trial[J].Lancet,2000,356 (9230):615-620.
  • 8Packer M ,Califf RM ,Konstam MA,et al.Comparison of omapatrilat and enalapril in patients with chronic heart failure : the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE) [J].Circulation, 2002,106(8):920-926.
  • 9Voors AA,Gori M,Liu LC,et al.Renal effects of the angi0tensin receptor neprilysin inhibitor LCZ696 in patients with heart failure and preserved ejection fraction [J].Eur J Heart Fail ,2015,17(5):510-517.
  • 10McMurray JJ, Packer M,Desai AS,et al.Angiotensin- neprilysin in hibition versus enalapril in heart failure[J].N Engl J Med,2014,371(11):993-1004.

引证文献6

二级引证文献37

中西医结合心脑血管病杂志
2013年 第9期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部